Swiss National Bank

Bank

Position in GLUE — Monte Rosa Therapeutics, Inc.

CIK 1582202 ZURICH, V8

Position in GLUE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,330,460

+$1,325,365 QoQ

Shares Held

96,300

+57.6% QoQ

Ownership

0.113%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#75

of 193 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. GLUE ranks #103 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,330,460	96,300	+57.6%	Shares	Sole	2026-08-11
2026-03-31	$1,005,095	61,100	-33.1%	Shares	Sole	2026-05-07
2023-09-30	$437,327	91,300	0.0%	Shares	Sole	2023-11-08
2023-06-30	$625,405	91,300	+118.4%	Shares	Sole	2023-08-09
2023-03-31	$325,622	41,800	-4.8%	Shares	Sole	2023-05-10
2022-12-31	$334,079	43,900	0.0%	Shares	Sole	2023-02-08
2022-09-30	$358,663	43,900	0.0%	Shares	Sole	2022-11-09
2022-06-30	$424,513	43,900	+59.6%	Shares	Sole	2022-08-09
2022-03-31	$385,550	27,500	+7.4%	Shares	Sole	2022-05-09
2021-12-31	$522,752	25,600	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.